Reozalimab, CAS 2445259-99-2

Product Description: Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12./[2]Reozalimab. IMGT/mAb-DB.

CAS Number: 2445259-99-2

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Cancer

Solubility: 10 mM in DMSO/H2O

Target: PD-1/PD-L1

• SKU: MEXHY-P9996-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9996-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated